ABL1 was first discovered more than 30 years ago as the oncogene in the Abelson murine leukaemia virus and was later identified as an oncogene that is associated with chromosome translocations in ...

A California company that has yet to even attempt a rocket launch has nonetheless inked a major deal with Lockheed Martin for dozens of missions over the next decade. Under terms of the block-buy ...

Detailed price information for Abacus Global Management Inc (ABL-Q) from The Globe and Mail including charting and trades.

ABL tests the powerpack of the second stage of its RS1 launch vehicle at Edwards Air Force Base, California. Credit: ABL Space Systems WASHINGTON — ABL Space Systems, a three-year-old startup ...

The structural basis for imatinib resistance in chronic myeloid leukaemia (CML) involves the emergence of imatinib-resistant BCR-ABL point mutations; mutations are usually those that impair drug ...

ABL Space Systems is looking to raise up to $100 million in new funding, and has just closed over $40 million, according to a new filing with the U.S. Securities and Exchange Commission. The company ...

Small-satellite launch company ABL Space Systems is gearing up for its first-ever liftoff. ABL completed a key fueling test, called a wet dress rehearsal, with its RS1 rocket on the pad at the Pacific ...

ABL Space Systems is dropping plans to compete in the launch market and is switching its focus to missile programs for U.S. national defense. ABL, founded in 2017, had attempted to reach orbit with ...

ABL’s RS1 Flight 2 and Flight 3 rockets in production. Credit: ABL Space Systems WASHINGTON — ABL Space Systems, a California-based launch startup, announced March 24 it has secured a $60 million ...

ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, announced that ABL Bio will receive a USD 40 million upfront payment for the license, research and collaboration agreement ...